Table 5. .
C/D ≤0.5 |
C/D > 0.5 |
|||||
Nonconverter Group (Mean ± SD) |
MRA-Converter Group (Mean ± SD) |
P |
Nonconverter Group (Mean ± SD) |
MRA-Converter Group (Mean ± SD) |
P |
|
Age (years) | 51.76 ± 10.6 | 45.50 ± 12.1 | 0.19* | 52.30 ± 11.3 | 49.63 ± 11.9 | 0.28† |
BCVA (Snellen) | 0.86 ± 0.1 | 0.91 ± 0.1 | 0.24* | 0.89 ± 0.1 | 0.86 ± 0.2 | 0.30† |
IOP (mmHg) | 23.40 ± 2.3 | 23.62 ± 2.6 | 0.82* | 23.32 ± 2.0 | 23.86 ± 2.3 | 0.23† |
Pachymetry (μm) | 567.00 ± 38.1 | 539.50 ± 35.0 | 0.09* | 554.09 ± 38.4 | 544.83 ± 41.7 | 0.27† |
C/D | 0.41 ± 0.2 | 0.44 ± 0.3 | 0.73* | 0.57 ± 0.5 | 0.64 ± 0.6 | 0.54† |
MD of SAP (dB) | −0.53 ± 1.4 | −0.32 ± 1.0 | 0.72* | −0.38 ± 1.4 | −0.66 ± 1.3 | 0.34† |
PSD of SAP | 1.52 ± 0.5 | 1.38 ± 0.4 | 0.51* | 1.62 ± 0.6 | 1.41 ± 0.5 | 0.09† |
Triglycerides (mg/dL) | 101.11 ± 47.9 | 85.10 ± 17.1 | 0.42* | 95.00 ± 42.2 | 80.09 ± 28.3 | 0.08† |
HDL cholesterol (mg/dL) | 54.41 ± 9.5 | 55.12 ± 8.1 | 0.86* | 48.54 ± 9.2 | 52.85 ± 7.7 | 0.02† |
LDL cholesterol (mg/dL) | 121.76 ± 28.6 | 130.25 ± 37.7 | 0.58* | 137.61 ± 29.2 | 125.23 ± 25.5 | 0.04† |
Plasma glucose (mg/dL) | 96.57 ± 14.4 | 102.37 ± 15.3 | 0.34* | 98.07 ± 14.4 | 92.75 ± 6.4 | 0.05† |
Systolic pressure (mmHg) | 128.13 ± 15.8 | 122.80 ± 14.5 | 0.42* | 126.81 ± 13.6 | 120.68 ± 12.2 | 0.03† |
Diastolic pressure (mmHg) | 76.24 ± 9.4 | 71.40 ± 7.7 | 0.22* | 75.46 ± 9.0 | 73.24 ± 10.2 | 0.26† |
Ocular perfusion pressure (mmHg) | 41.92 ± 6.7 | 37.62 ± 8.1 | 0.13* | 41.70 ± 7.0 | 38.76 ± 8.1 | 0.06† |
Sex (M/F) | 65/76 | 4/2 | 0.42‡ | 41/44 | 12/18 | 0.53‡ |
n | 141 | 6 | 85 | 30 |
< 0.002 was considered statistically significant.
Mann-Whitney's U test.
Student's t-test.
Chi-square test.